Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000940180-00-000155
Filing Date
2000-02-14
Accepted
2000-02-14 00:00:00
Documents
3
Group Members
ANTHONY B. EVNINANTHONY SUNDAVID R. HATHAWAYKIMBERLEY A. RUMMELSBURGPATRICK F. LATTERELLRAY A. ROTHROCKTED H. MCCOURTNEYVENROCK ASSOCIATESVENROCK ASSOCIATES II, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13G SC 13G/A 34425
2 POWER OF ATTORNEY EX-24.1 2504
3 AGREEMENT EX-99.1 2323
  Complete submission text file 0000940180-00-000155.txt   41775
Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

EIN.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231

Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Subject) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47359 | Film No.: 543824
SIC: 2834 Pharmaceutical Preparations